Piramal Imaging SA and Ci-Co Healthcare announce commercial approval of Neuraceq in Korea Neuraceq is the first diagnostic radiotracer to support the early diagnosis of Alzheimer’s disease (AD) that is commercially…
Piramal Imaging supports research study assessing value of PET scans in Alzheimer’s disease and… Alzheimer’s Association and American College of Radiology lead IDEAS trial to inform medicare coverage of brain amyloid imaging
